Atlas Trials

Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia

Clinical trial NCT05135286 · COMPLETED

Trial details

NCT number
NCT05135286
Sponsor
Visus Therapeutics
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Presbyopia
Start date
2022-03-15
Primary completion
2025-03-13
Enrollment
629

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.